UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040734
Receipt number R000045585
Scientific Title Fukushima Large Vessel Occlusion Stroke Registry
Date of disclosure of the study information 2020/07/01
Last modified on 2023/07/03 14:09:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Fukushima Large Vessel Occlusion Stroke Registry

Acronym

Fukushima LVO Registry

Scientific Title

Fukushima Large Vessel Occlusion Stroke Registry

Scientific Title:Acronym

Fukushima LVO Registry

Region

Japan


Condition

Condition

Acute cerebral major artery occlusion

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to understand the status of treatment for acute cerebral major artery occlusion in Fukushima Prefecture and verify that mechanical thrombectomy is being performed appropriately.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)modified Rankin Scale at 90 days after onset
2)Symptomatic intracranial hemorrhage

Key secondary outcomes

1)Successful recanalization
2)The time required from the onset to the successful recanalization
3)Death within 90 days after onset


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

For patients who meet the following criteria 1) and 2), and for patients who fall under any of 3) from 6).
1)Acute ischemic stroke patients who hospitalized in Fukushima Prefecture within 24 hours from the onset or last known well.
2)Patients with acute intracerebral major vessel occlusion confirmed by CTA, MRA, or cerebral angiography.
3)Patients who underwent mechanical thrombectomy.
4)Patients with other occlusions besides ICA or M1 proximal portion.
5)Patients whose NIHSS is below 6 points.
6Patients whose CT or DWI-ASPECTS is below 6 points.

Key exclusion criteria

1)Patients considered inappropriate to participate in the study.
2)Patients with intraoperative stroke onset.
3)Patients with recurrent acute intracerebral major vessel occlusion.

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Kiyoshi
Middle name
Last name Saito

Organization

Fukushima Medical University

Division name

Department of Neurosurgery

Zip code

9601295

Address

1 Hikarigaoka, Fukushima, Japan

TEL

0245471266

Email

kiyoshis@fmu.ac.jp


Public contact

Name of contact person

1st name Takao
Middle name
Last name Kojima

Organization

Fukushima Medical University

Division name

Department of Neurosurgery

Zip code

9601295

Address

1 Hikarigaoka, Fukushima, Japan

TEL

0245471268

Homepage URL


Email

neuro-s@fmu.ac.jp


Sponsor or person

Institute

Department of Neurosurgery, Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Neurosurgery, Fukushima Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University

Address

1 Hikarigaoka, Fukushima, Japan

Tel

0245471825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

枡記念病院、総合南東北病院、福島赤十字病院、南相馬市立総合病院、太田西ノ内病院、公立藤田総合病院、南東北福島病院、星総合病院、寿泉堂綜合病院


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

217

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 03 Month 30 Day

Date of IRB

2020 Year 05 Month 25 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 06 Month 30 Day


Other

Other related information

Primary outcomes
1)modified Rankin Scale at 90 days after onset
2)Symptomatic intracranial hemorrhage


Management information

Registered date

2020 Year 06 Month 12 Day

Last modified on

2023 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045585


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name